Compare UMH & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UMH | TNDM |
|---|---|---|
| Founded | 1968 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | N/A | 2013 |
| Metric | UMH | TNDM |
|---|---|---|
| Price | $15.23 | $25.25 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 19 |
| Target Price | $17.75 | ★ $26.95 |
| AVG Volume (30 Days) | 388.5K | ★ 2.3M |
| Earning Date | 01-01-0001 | 05-19-2026 |
| Dividend Yield | ★ 5.97% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,014,736,000.00 |
| Revenue This Year | $10.80 | $10.96 |
| Revenue Next Year | $8.34 | $9.33 |
| P/E Ratio | $203.74 | ★ N/A |
| Revenue Growth | N/A | ★ 7.93 |
| 52 Week Low | $13.95 | $10.00 |
| 52 Week High | $19.14 | $29.65 |
| Indicator | UMH | TNDM |
|---|---|---|
| Relative Strength Index (RSI) | 35.03 | 63.72 |
| Support Level | $14.76 | $19.04 |
| Resistance Level | $15.41 | N/A |
| Average True Range (ATR) | 0.35 | 1.83 |
| MACD | -0.10 | 0.65 |
| Stochastic Oscillator | 27.27 | 63.44 |
UMH Properties Inc together with its subsidiaries is a real estate investment trust. It is engaged in the business of ownership and operation of manufactured home communities - leasing manufactured homesites to residents . The Company also leases manufactured homes to residents and, through its wholly-owned taxable REIT subsidiary, UMH Sales and Finance, Inc. sells and finances the sale of manufactured homes to residents and prospective residents of its communities and for placement on customers' privately-owned land. The company also owns the land, utility connections, streets, lighting, driveways, common area amenities, and other capital improvements. It earns income from lease agreements for their sites and homes, where the company is the lessor.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.